PARACELSUS HEALTHCARE CORP
8-K, 1997-07-07
GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Previous: COREFUNDS INC, 497, 1997-07-07
Next: AMERICAN GENERAL VENTURES INC, 10KSB, 1997-07-07







                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549


                                   FORM 8-K


               CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                    THE SECURITIES AND EXCHANGE ACT OF 1934


        Date of Report (Date of earliest event reported): June 27, 1997


                        Commission file number 1-12055



                       PARACELSUS HEALTHCARE CORPORATION
            (Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>



                        California                   95-3565943
<S>                                             <C>
        (State or other jurisdiction of              (IRS Employer
        incorporation or organization)               Identification No.)
</TABLE>


                 515 W. Greens Road, Suite 800, Houston, Texas
                   (Address of principal executive offices)


<TABLE>
<CAPTION>
<S>                                   <C>
                    77067                                   (281) 774-5100
                 (Zip Code)           (Registrant's telephone number, including
                                                              area code)
</TABLE>
<PAGE>
ITEM 6.   RESIGNATION OF REGISTRANT'S DIRECTOR

On June 27, 1997, Mr. James A. Conroy submitted his resignation as a director
of Paracelsus Healthcare Corporation (the "Company"). In his resignation
letter, which is hereby filed as Exhibit 17, Mr. Conroy stated " My
resignation  is  due  to  my  unhappiness with the unwillingness of the Special
Committee  to  address  the  issue   of   the  old  Paracelsus  board  members'
responsibility for the reporting and accounting  failures  found by the Special
Committee,  as  well as my strong disagreement with the decision  made  by  the
other board members  not  to make full disclosure of the results of the Special
Committee's investigation to the Securities and Exchange Commission." 

The  Company's  management, while accepting Mr. Conroy's resignation,
does not agree with  Mr.  Conroy's  positions  on  the  matters addressed above
because of the following:

(i)  The Special Committee's investigation sought to uncover all facts relevant
     to the responsibility of the directors of premerger Paracelsus for the
     reporting and accounting failures reflected in the Company's restatement
     of its financial statements. Based on these facts, a majority of the
     Special Committee members, including a completely disinterested
     nonmanagement director, concluded  that it was not in the Company's best
     interests for the Special Committee to make recommendations concerning the
     old Paracelsus' board members at that time. The Company's position was
     fully supported by Wilmer, Cutler & Pickering, its outside legal counsel
     which firm had been retained by the Special Committee to conduct such
     inquiry.

(ii) During the last Board Meeting, Mr. Conroy motioned that the Company should
     waive its attorney-client and work product privileges so as to permit
     disclosure of the detailed facts uncovered in the Special Committee's
     investigation to the Securities and Exchange Commission. During the 
     discussion of that motion, Wilmer, Cutler & Pickering advised the Company
     that, given the pendency of the shareholder and derivative litigation and
     other factors, waiver of the privileges was not in the best interests of
     the Company. The Company was further reassured by Wilmer, Cutler &
     Pickering, that based on the available facts, all legally
     required public disclosures concerning the results of the Special
     Committee's investigation had already been made. Based on this advice,
     there was no second to Mr. Conroy's motion.

(iii)The Board is concerned that Mr. Conroy's positions may reflect his
     interests as a member of a large group of former Champion shareholders,
     rather that the interests of the Company, its shareholders and all of its
     other constituent groups.

ITEM 7.  EXHIBIT

17   Letter  re director resignation of Mr. James Conroy.

<PAGE>



                                     SIGNATURE

Pursuant  to  the  requirements  of the Securities Exchange Act  of  1934,  the
Registrant has duly caused this report  to  be  signed  on  its  behalf  by the
undersigned thereunto duly authorized.


                                            Paracelsus Healthcare Corporation
                                                           (Registrant)

                                                  /s/ James G. VanDevender
Dated: July 7, 1997                      By:   ___________________________

                                                     James G. VanDevender
                                                  Executive Vice President,
                                                   Chief Financial Officer
                                                       & Director





                                  OLYMPUS PARTNERS
                            Metro Center, One Station Place
                              Stanford, Connecticut 06902
                                   (203)353-5900


James A. Conroy
Partner

                                                       June 27, 1997

Via Facsimile: 281-774-5110
- ---------------------------

The Board of Directors
Paracelsus Healthcare Corporation
515 West Greens Road
Houston, Texas 77067

Attention: Mr. Charles R. Miller

Gentlemen:

I  hereby  resign  as  a  director  of  Paracelsus  effective  immediately.  My
resignation  is  due  to  my  unhappiness with the unwillingness of the Special
Committee  to  address  the  issue   of   the  old  Paracelsus  board  members'
responsibility for the reporting and accounting  failures  found by the Special
Committee,  as  well as my strong disagreement with the decision  made  by  the
other board members  not  to make full disclosure of the results of the Special
Committee's investigation to the Securities and Exchange Commission.

I request that this letter  be  filed  in  a  Form 8-K within the required time
period.


                                             Sincerely,

                                             /s/ James A. Conroy

JAC/jbp

cc: Arthur F. Mathews, Esq.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission